Methylnaltrexone Bromide
Brand name: Relistor
Rank #295 of 500 drugs by total cost
$39.8M
Total Cost
16,356
Total Claims
$39.8M
Total Cost
602
Prescribers
$2,432
Cost per Claim
2,734
Beneficiaries
16,871
30-Day Fills
$66K
Avg Cost/Provider
27
Avg Claims/Provider
About Methylnaltrexone Bromide
Methylnaltrexone Bromide (sold as Relistor) was prescribed 16,356 times by 602 Medicare Part D providers in 2023, costing the program $39.8M. At $2,432 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 292 | Obeticholic Acid (Ocaliva) | $40.6M | 4,131 |
| 293 | Doxycycline Hyclate (Doxycycline Hyclate) | $40.5M | 2,023,357 |
| 294 | Carbamazepine (Carbamazepine) | $40.4M | 389,090 |
| 295 | Methylnaltrexone Bromide (Relistor) | $39.8M | 16,356 |
| 296 | Spironolactone (Spironolactone) | $39.4M | 3,126,938 |
| 297 | Varenicline Tartrate (Varenicline Tartrate) | $38.8M | 87,274 |
| 298 | Propranolol Hcl (Propranolol Hcl) | $38.7M | 1,168,547 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology